[
  {
    "ts": null,
    "headline": "Why Analysts See Centene’s Story Shifting Amid Margin Recovery Hopes and Medicaid Risks",
    "summary": "Centene's fair value estimate has been nudged higher from $39.41 to $39.94 per share, while the discount rate in valuation models has ticked down from 7.37% to 7.30%. This signals a slightly more constructive view on risk even as Street opinion grows more divided between bullish and cautious camps. These fine tuned inputs reflect a tug of war between optimism around Q3 execution and margin recovery and lingering concerns about Medicaid exposure, contract volatility, and the broader...",
    "url": "https://finnhub.io/api/news?id=52d85f70ca9670f7888014bd3f703109adbd9de686b2ec6808b757da3a5fc304",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764972257,
      "headline": "Why Analysts See Centene’s Story Shifting Amid Margin Recovery Hopes and Medicaid Risks",
      "id": 137715908,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CNC",
      "source": "Yahoo",
      "summary": "Centene's fair value estimate has been nudged higher from $39.41 to $39.94 per share, while the discount rate in valuation models has ticked down from 7.37% to 7.30%. This signals a slightly more constructive view on risk even as Street opinion grows more divided between bullish and cautious camps. These fine tuned inputs reflect a tug of war between optimism around Q3 execution and margin recovery and lingering concerns about Medicaid exposure, contract volatility, and the broader...",
      "url": "https://finnhub.io/api/news?id=52d85f70ca9670f7888014bd3f703109adbd9de686b2ec6808b757da3a5fc304"
    }
  }
]